Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.
Exhibit Hall, Learning Theater 1
Boston Convention and Exhibition Center

Program Description

Please join Ayodeji Adegunsoye, MD, of the University of Chicago, as he discusses OFEV (nintedanib) capsules. Dr. Adegunsoye will review the safety and efficacy of OFEV, explore the mechanism of action for nintedanib, underscore the importance of identifying appropriate patients for treatment, and provide insights into the pharmacology of OFEV. This presentation is made on behalf of Boehringer Ingelheim Pharmaceuticals, Inc.

This is a non-CME event and does not qualify for CME, CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2024 conference sessions. This event is not endorsed by CHEST and does not reflect  the views or opinions of CHEST.

This presentation is open to all CHEST 2024 attendees. Onsite registration will occur for conference registrants only at the presentation entrance on a first-come, first-served basis. Presentation content has been reviewed for consistency with FDA guidelines and is not approved for continuing education credit. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.

Speaker

Presenter: Ayodeji Adegunsoye, MD
University of Chicago Department of Medicine
Assistant Professor of Medicine
Chicago, IL